Clinical Validation of Vital-PICASO for Predicting Cardiac Arrest Within 24 Hours
Key facts
- Who runs it
- Huinno AIM
- Where
- South Korea1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 387 people enrolled
- Started
- 20 Aug 2025
- Ended
- 19 Dec 2025
- Type of study
- Observational, 2 groups
- Record updated
- 3 August 2026
Who can take part
- Age
- 19 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 23 criteriaShow less
Who can take part
- General Criteria
- Male or female patient aged 19 years or older at the time the clinical data were recorded
- Electronic medical record data available between January 1, 2023, and May 31, 2025
- Admission to a general ward for at least 12 hours
- Availability of the required vital-sign data, including systolic blood pressure, diastolic blood pressure, heart rate, respiratory rate, body temperature, and oxygen saturation when available
- Clinical data not previously used in the development of Vital-PICASO; Cardiac Arrest-Positive Group
- In-hospital cardiac arrest occurred in a general ward
- Cardiac arrest was documented in the electronic medical record and was followed by at least one of the following resuscitation procedures:
- High-quality cardiopulmonary resuscitation
- Defibrillation
- Advanced life support
- Vital-sign data were available for up to 72 hours before the cardiac arrest
- If cardiac arrest occurred within 24 hours after admission to the general ward, all available vital-sign data recorded before the event were included
- If a patient experienced multiple cardiac arrest events during the study period, only the first eligible event was included; Cardiac Arrest-Negative Group
- No cardiac arrest or other predefined clinical deterioration occurred during the selected general ward admission period
- The patient was selected from the same general ward as patients in the cardiac arrest-positive group
- Vital-sign data were available from a time period comparable with the cardiac arrest-positive group or within 72 hours after admission to the general ward
- Only one eligible data segment was included per patient
- The data were considered appropriate for inclusion in the cardiac arrest-negative group by the investigator
Who cannot take part
- Cardiac arrest occurred outside a general ward
- A do-not-resuscitate order was in effect at the time of data collection
- Pregnancy at the time of data collection or within 3 months after delivery
- The data were considered inappropriate for the study by the investigator
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of this retrospective study is to evaluate the clinical performance of Vital-PICASO, an artificial intelligence-based biological signal analysis software designed to predict the risk of in-hospital cardiac arrest within 24 hours using vital-sign data collected from adult general ward inpatients.
Read full original descriptionShow less
Electronic medical record data from patients aged 19 years or older who were admitted to a general ward at Seoul National University Hospital will be retrospectively reviewed. Vital-sign variables include systolic blood pressure, diastolic blood pressure, heart rate, respiratory rate, body temperature, and, when available, oxygen saturation.
Eligible data will be classified as cardiac arrest-positive or cardiac arrest-negative according to predefined reference-standard criteria. The blinded datasets will then be analyzed using Vital-PICASO, and the software-generated risk scores will be compared with the reference-standard classifications. Predictive performance will be evaluated separately using models that include oxygen saturation and models that do not include oxygen saturation.
The 2 groups in the trial
- Cardiac Arrest-Positive Group
General ward inpatients with an eligible in-hospital cardiac arrest documented in the electronic medical record and followed by resuscitation involving cardiopulmonary resuscitation, defibrillation, or advanced life support.
- Cardiac Arrest-Negative Group
General ward inpatients without cardiac arrest or other predefined clinical deterioration during the selected hospitalization and observation period.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Clinical Validity of an AI-Based Biological Signal Analysis Software Vital-PICASO for Predicting the Risk of Cardiac Arrest Within 24hrs Using Vital Sign (SBP, DBP, HR, RR, BT, SpO2) From General Ward Inpatients; A Retrospective, Single-Center, Single-Arm, Superiority-Confirmatory Clinical Trial
- Record updated
- 3 August 2026